开拓药业-B拟发行3048.75万股认购股份 净筹约4978万港元
KINTOR PHARMAKINTOR PHARMA(HK:09939) Zheng Quan Shi Bao Wang·2025-11-13 00:16

Core Viewpoint - The company plans to issue 30.4875 million subscription shares to Huayuan Management Consulting (Hong Kong) Limited at a subscription price of HKD 1.64 per share, representing a discount of approximately 15.03% compared to the last closing price of HKD 1.93 on the Stock Exchange [1] Fundraising and Use of Proceeds - The subscription is expected to raise approximately HKD 49.78 million, which will be used for the company's daily operational funds and the Phase III clinical trial of KX-826 [1]